Combined pembrolizumab and pegylated liposomal doxorubicin in platinum resistant ovarian cancer: A phase 2 clinical trial

Elizabeth K. Lee, Niya Xiong, Su–Chun Cheng, William T. Barry, Richard T. Penson, Panagiotis A. Konstantinopoulos, Mark A. Hoffman, Neil S. Horowitz, Don S. Dizon, Elizabeth H. Stover, Alexi A. Wright, Susana M. Campos, Carolyn Krasner, Stephanie Morrissey, Christin Whalen, Roxanne Quinn, Ursula A. Matulonis, Joyce F. Liu